[go: up one dir, main page]

NO981818L - FremgangsmÕte for Õ mobilisere hematopoetiske stamceller - Google Patents

FremgangsmÕte for Õ mobilisere hematopoetiske stamceller

Info

Publication number
NO981818L
NO981818L NO981818A NO981818A NO981818L NO 981818 L NO981818 L NO 981818L NO 981818 A NO981818 A NO 981818A NO 981818 A NO981818 A NO 981818A NO 981818 L NO981818 L NO 981818L
Authority
NO
Norway
Prior art keywords
stem cells
hematopoietic stem
procedure
mobilizing hematopoietic
mobilizing
Prior art date
Application number
NO981818A
Other languages
English (en)
Norwegian (no)
Other versions
NO981818D0 (no
Inventor
Louis Martin Pelus
Andrew Garrison King
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO981818D0 publication Critical patent/NO981818D0/no
Publication of NO981818L publication Critical patent/NO981818L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/521Chemokines
    • C07K14/522Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/193Colony stimulating factors [CSF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/49Platelet-derived growth factor [PDGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO981818A 1995-10-24 1998-04-23 FremgangsmÕte for Õ mobilisere hematopoetiske stamceller NO981818L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54726295A 1995-10-24 1995-10-24
PCT/US1996/017074 WO1997015595A1 (en) 1995-10-24 1996-10-24 Method of mobilizing hematopoietic stem cells

Publications (2)

Publication Number Publication Date
NO981818D0 NO981818D0 (no) 1998-04-23
NO981818L true NO981818L (no) 1998-06-17

Family

ID=24183989

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981818A NO981818L (no) 1995-10-24 1998-04-23 FremgangsmÕte for Õ mobilisere hematopoetiske stamceller

Country Status (14)

Country Link
EP (1) EP0866806A4 (es)
JP (1) JPH11512747A (es)
KR (1) KR19990066997A (es)
AR (1) AR004093A1 (es)
AU (1) AU712235B2 (es)
BR (1) BR9611173A (es)
CZ (1) CZ120298A3 (es)
HU (1) HUP9802531A3 (es)
NO (1) NO981818L (es)
NZ (1) NZ321789A (es)
PL (1) PL326364A1 (es)
TR (1) TR199800742T2 (es)
WO (1) WO1997015595A1 (es)
ZA (1) ZA968896B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6042821A (en) * 1995-11-21 2000-03-28 Smithkline Beecham Corporation Method of treating sepsis with chemokines
US6290948B1 (en) * 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
ATE293987T1 (de) * 1997-11-26 2005-05-15 Smithkline Beecham Corp Methode zur mobilisierung hematopoietischer stammzellen
CA2339900A1 (fr) * 1999-06-08 2000-12-14 Transgene S.A. Composition destinee a la mise en oeuvre d'un traitement cytotoxique, notamment antitumoral ou antiviral, chez un mammifere
AU2002216749A1 (en) * 2000-06-30 2002-01-14 Smithkline Beecham Corporation Chemokine conjugates
JP3563366B2 (ja) 2001-05-07 2004-09-08 独立行政法人 科学技術振興機構 蛋白質高次構造に対してアンフォールド活性を有する蛋白質多量体
IL146970A0 (en) * 2001-12-06 2002-08-14 Yeda Res & Dev Migration of haematopoietic stem cells and progenitor cells to the liver
US7375192B2 (en) 2002-05-01 2008-05-20 Human Genome Sciences, Inc. Antibodies that specifically bind to chemokine beta-4
TWI589587B (zh) 2010-11-19 2017-07-01 衛材R&D企管股份有限公司 中和性抗-ccl20抗體

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1378522A3 (en) * 1993-06-08 2004-02-04 SmithKline Beecham Corporation Methods of enhancing bioactivity of chemokines
GB9426012D0 (en) * 1994-12-22 1995-02-22 British Biotech Pharm Mobilisation of haematopoietic cells
GB9517014D0 (en) * 1995-08-19 1995-10-25 British Biotech Pharm Haematopoietic recovery

Also Published As

Publication number Publication date
HUP9802531A2 (hu) 1999-02-01
TR199800742T2 (xx) 1998-08-21
AU712235B2 (en) 1999-11-04
EP0866806A1 (en) 1998-09-30
NZ321789A (en) 2000-07-28
AU7520996A (en) 1997-05-15
ZA968896B (en) 1997-04-24
PL326364A1 (en) 1998-09-14
EP0866806A4 (en) 2002-01-09
JPH11512747A (ja) 1999-11-02
BR9611173A (pt) 1999-03-30
HUP9802531A3 (en) 2001-08-28
MX9803217A (es) 1998-09-30
WO1997015595A1 (en) 1997-05-01
KR19990066997A (ko) 1999-08-16
NO981818D0 (no) 1998-04-23
AR004093A1 (es) 1998-09-30
CZ120298A3 (cs) 1998-09-16

Similar Documents

Publication Publication Date Title
NO981818L (no) FremgangsmÕte for Õ mobilisere hematopoetiske stamceller
BRPI9715334B8 (pt) agentes estrogênicos e composição farmacêutica compreendendo os mesmos.
JPS5611430A (en) Contact lens
FI834872A0 (fi) Substituerade 4-aminoetylen-kromaner och -kromener, foerfaranden foer deras framstaellning och deraanvaendning som laekemedel
DE3873957D1 (de) Verfahren zur behandlung schwach aktiver organischer abfaelle von kernkraftwerken mittels anaerobischer fermentation.
TR199701012T1 (xx) Fungisidal kompozisyon.
NO974260L (no) Nye definerte enzymblandinger for oppnåelse av celler og behandling av sår
JPS5349855A (en) Method of anaerobic digestion of organic waste matter
EA199700279A1 (ru) Растительный промотор и способ генной экспрессии с использованием указанного промотора
ATE183385T1 (de) Lyopilisierte, wirkstoffhaltige emulsion
NO171416C (no) Anvendelse av gamma-glutamyltranspeptidase
AR009614A1 (es) Secuencias de adn reguladoras inducibles por nematodos que pueden ser utilizadas para expresar las secuencias de adn en celulas de plantas
DE3855002D1 (de) Verfahren zur Herstellung von Dodecahydro-3a,6,6,9a-tetramethylnaphto(2,1-b)furan
ES2153584T3 (es) Piridiniminil-1,2-benzisoxazol y -benzisotiazol como antipsicoticos.
ATE310095T1 (de) Verfahren zur modulierung des niveaus von organischen schwefelverbindungen in pflanzen
JPS53124693A (en) Preparation of soy malt
YU47189B (sh) Postupak za proizvodnju ulja kamilice sa visokim sadržajem prirodnih poliina
ATE118816T1 (de) Verfahren zur herstellung von acci- restriktionsendonuklease und -methylase.
NO985041L (no) FremgangsmÕte for fremstilling av modent benmorfogenetisk protein
JPS5295872A (en) Apparatus for breeding cattles and treating excretions
JPS5211648A (en) Waste water treatment method
JPS541594A (en) Method of purifying fuel oil of shipping
JPS53115565A (en) Method of treating organic waste water
JPS57170180A (en) Removal of smell of rifined sake made from old rice
SE7809415L (sv) Sett att behandla fororenade vattenhaltiga medier

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application